Rejected at 3:16 a.m. Nov, 01, 2023 ] by dollajas
Author: kfw001
Related Note: 1514576041266
Rationale for change

Easy to remember MACrolide for MAC
Source: Other - Me

Rejection reason

not necessary, add to your own personal fields

Text Text
Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Empty field
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#B&B::08_Infectious_Disease::03_HIV::01_HIV_Infection::Extra #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::23_Rifamycins #AK_Step2_v12::#B&B::08_Infectious_Disease::03_HIV::03_HIV_Complications::Extra #AK_Step2_v12::#UWorld::COMLEX::100060 #AK_Other::!AK_UpdateTags::AnKing_Image::Mujeeb::HIV_infection_management #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step2_v12::#Resources_by_rotation::IM::ome::infection::hiv #AK_Step1_v12::^Other::^FA_Updates::FA2018 #AK_Step2_v12::#SketchyIM::09_Infectious_Diseases::Retired_Lessons::04_HIV_&_AIDS::02_AIDS_SOAP_[OLD_VERSION] #AK_Step1_v12::#B&B::14_Infectious_Disease::02_Bacteria::08_Mycobacteria #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::26_Antituberculous_drugs::*Rifamycins #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_2::Antibacterials::Antimycobacterials #AK_Step2_v12::#FirstAid::14_Pulm::07_Mycobacterial_Infections::02_Nontuberculous_Mycobacteria #AK_Other::!AK_UpdateTags::AnKing_Image::!Subjects::Microbiology::HIV_infection_management #AK_Step1_v12::^Other::^EXPN #AK_Step2_v12::#Subjects::Microbiology::01_Bacteria::08_Mycobacteria::Mycobacterium_Avium_Complex::Prophylaxis #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step2_v12::#Resources_by_rotation::IM::amboss_medicalark #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::02_Inhibitors_of_Bacterial_Protein_Synthesis::02_Macrolides #AK_Step2_v12::Original_decks::Dorian::im::ome::infection::hiv #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::14_Macrolides #AK_Step1_v12::#Bootcamp::Microbiology::35_Opportunistic_Infections::07_Cytomegalovirus,_Disseminated_Mycobacterial_Non-Tuberculous_Disease #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::16_Macrolides #AK_Step2_v12::Original_decks::MedicalArk::im::amboss #AK_Step1_v12::#Physeo::09_Pharm::05_Antibiotics::22_Dapsone,_Rifamycins,_Clofazimine_(Leprosy_Drugs) #AK_Step1_v12::#SketchyMicro::01_Bacteria::08_Mycobacteria::03_Mycobacterium_avium_intracellulare,_Mycobacterium_scrofulaceum,_Mycobacterium_marinum #AK_Step2_v12::!Shelf::IM::no_dupes #AK_Other::!AK_UpdateTags::Table::HIV_Opportunistic_Prophylaxis #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::03_Antimycobacterials::02_Leprosy_Drugs::zanki_extra #AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::27_Antimycobacterial_therapy #AK_Step1_v12::#Bootcamp::Microbiology::36_Antibiotics::24_Pyrazinamide_Ethambutol_Dapsone_and_Clofazimine #AK_Step2_v12::#AMBOSS::IF0Yj3 #PANCE::INFECTIOUS_DISEASE::mycobacterial_diseases #AK_Step2_v12::#UWorld::Step::3252